1. News
  2. Sector

  3. Pharma & Healthcare

Teva proposes to acquire Mylan for $82.00 Per Share in Cash and Stock

India Infoline News Service | Mumbai | April 22, 2015 08:34 IST

The Teva cash and stock proposal provides Mylan stockholders with a substantial premium and immediate cash value, as well as significant potential for future value creation through participation in a financially and commercially stronger company.

Sun Pharma nosedives, Daiichi's bulk deal major contributor

India Infoline News Service | Mumbai | April 21, 2015 21:10 IST

In what is clearly one of the biggest value bulk deals in recent times, Japanese pharma major Daiichi Sankyo sold nearly 21.49 crore shares of Sun Pharma at the NSE counter today. The total traded volume was a staggering 26.57 crore and the traded value was a staggering Rs. 24,817. 52 crore.

Sun Pharma slumps 9% on Daiichi exit

India Infoline News Service | Mumbai | April 21, 2015 16:02 IST

Japanese firm Daiichi Sankyo will be selling its 9 percent holding in Sun Pharma, which it had acquired following the Ranbaxy-Sun Pharma merger block deals today.

Claris Lifesciences ends higher on receiving approval for Fluconazole Injection

India Infoline News Service | Mumbai | April 21, 2015 15:58 IST

Claris Lifesciences ended 1% up at Rs. 277 after it has received the Supplemental Abbreviated New Drug Application approval for Fluconazole Injection in US.

Claris receives Supplemental ANDA approval for Fluconazole Injection

India Infoline News Service | Mumbai | April 21, 2015 14:58 IST

Claris currently marketing Fluconazole in 2 mg/ml formulation packed in 100 ml and 200 ml PVC Bags and now with the approval of supplemental ANDA, Claris is the only company to be able to sell Fluconazole in 50 ml variant in the US.

Cipla, Ranbaxy and Biocon adopt Cirrius PharmaCRM platform

India Infoline News Service | Mumbai | April 21, 2015 14:22 IST

The platform rides on three components, the base CRM platform, Closed Loop Marketing and the Phyzii engagement platform that fuels effective interactions between pharmaceutical companies and their network of medical reps, physicians, patients and the supply chain.

Claris Lifesciences gains 4% after receiving approval for Fluconazole injection

India Infoline News Service | Mumbai | April 21, 2015 12:51 IST

The company receives Supplemental ANDA approval for Fluconazole injection in 50 ml PVC Bags Claris will be only company offering Fluconzole Injection USP in 50ml PVC bags in the US.

Temasek Holdings to invest Rs. 945 crores in Glenmark Pharma

India Infoline News Service | Mumbai | April 21, 2015 10:16 IST

At the board meeting held today, Glenmark decided to raise funds by way of issue of upto 108,00,000 equity shares of Re. 1/- each on preferential basis for cash to Aranda,

Claris Life gains on fund buying

India Infoline News Service | Mumbai | April 21, 2015 09:42 IST

Claris Lifesciences is trading on a positive note after TATA AIA Life Insurance bought 592,000 shares yesterday at Rs. 270 on BSE.

Sun Pharma slumps on Daiichi exit plan

India Infoline News Service | Mumbai | April 21, 2015 09:42 IST

The stock has crashed over 10 percent on the back of heavy volume.

Daiichi Sankyo plans to sell 9% stake in Sun Pharma

India Infoline News Service | Mumbai | April 21, 2015 08:32 IST

The Japanese drugmaker, which was earlier purchased by Ranbaxy in 2008 had a tough time dealing with US FDA claims over Ranbaxy's clearances for its products.

Anuh Pharma hits 52-week high; up 10%

India Infoline News Service | Mumbai | April 20, 2015 16:23 IST

The company is working on 10 new products, of which the company is planning to launch 4 products in FY16.

Glenmark Pharma gains 4% on fund raising plans

India Infoline News Service | Mumbai | April 20, 2015 16:11 IST

The company said in a notice to BSE that it will hold extraordinary general meeting on 13 May to approve offering of 10.8 million shares to Aranda Investments (Mauritius) Pte Ltd at Rs. 875 apiece.

Anuh Pharma hits 52-week high

India Infoline News Service | Mumbai | April 20, 2015 12:00 IST

The stock is trading higher on expecting 25 percent revenue growth in FY16.

Lupin launches Zaxine in Canada

India Infoline News Service | Mumbai | April 20, 2015 11:34 IST

The agreement grants Lupin exclusive rights to promote, distribute and market Zaxine in the Canada.

Claris Lifesciences zooms 4.5% on settlement with Fresenius Kabi USA

India Infoline News Service | Mumbai | April 20, 2015 10:34 IST

Claris Lifesciences announces settlement of litigations and license agreement for its generic DIPRIVAN in USA.

Glenmark Pharma surges 2.7% on fund raising plans

India Infoline News Service | Mumbai | April 20, 2015 09:33 IST

The stock has jumped over 5 percent in the early trades.

Snapdeal banned to sell prescription drugs by FDA

India Infoline News Service | Mumbai | April 18, 2015 15:24 IST

Department of Food and Drug Administration (FDA), has banned e-commerce firm Snapdeal.com for selling prescription drug online.

Piramal Enterprises to acquire majority equity stake in Health SuperHiway

India Infoline News Service | Mumbai | April 18, 2015 13:10 IST

PEL has invested INR 60 lakh today in cash which will make it a minority shareholder in HealthHiway. PEL will be investing up to an additional INR44.2 crore in the next 33 months, if HealthHiway achieves a set of specified growth milestones that are based on acquisition of hospital data partnerships.

Back to Top

Reports
News